Vincristine-induced peripheral neuropathy in childhood acute lymphoblastic leukemia: genetic variation as a potential risk factor

QY Yang, YH Hu, HL Guo, Y Xia, Y Zhang… - Frontiers in …, 2021 - frontiersin.org
Vincristine (VCR) is the first-line chemotherapeutic medication often co-administered with
other drugs to treat childhood acute lymphoblastic leukemia. Dose-dependent neurotoxicity …

Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia

F Ceppi, C Langlois-Pelletier, V Gagné… - …, 2014 - Taylor & Francis
Background: Vincristine (VCR) is a standard component in the treatment of childhood acute
lymphoblastic leukemia (ALL). VCR cytotoxicity is primarily due to its ability to disrupt the …

Progress toward the development of noscapine and derivatives as anticancer agents

A DeBono, B Capuano… - Journal of medicinal …, 2015 - ACS Publications
Many nitrogen-moiety containing alkaloids derived from plant origins are bioactive and play
a significant role in human health and emerging medicine. Noscapine, a …

Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia

J Gregers, H Green, IJ Christensen, K Dalhoff… - The …, 2015 - nature.com
The membrane transporter P-glycoprotein, encoded by the ABCB1 gene, influences the
pharmacokinetics of anti-cancer drugs. We hypothesized that variants of ABCB1 affect …

Advances in antitumor activity and mechanism of natural steroidal saponins: A review of advances, challenges, and future prospects

F Wang, L Liang, M Yu, W Wang, IH Badar, Y Bao… - Phytomedicine, 2024 - Elsevier
Background Cancer, the second leading cause of death worldwide following cardiovascular
diseases, presents a formidable challenge in clinical settings due to the extensive toxic side …

Effect of ABCB1 most frequent polymorphisms on the accumulation of bictegravir in recombinant HEK293 cell lines

J De Greef, M Akue, N Panin, KA Delongie, M André… - Scientific reports, 2024 - nature.com
Bictegravir, a key second-generation integrase strand transfer inhibitor in the treatment of
HIV, is subject to active efflux transport mediated by ABCB1 (P-glycoprotein). Several coding …

Genetic variants in genes involved in mechanisms of chemoresistance to anticancer drugs

J JG Marin, O Briz, MJ Monte… - Current cancer drug …, 2012 - ingentaconnect.com
Refractoriness to the pharmacological treatment of cancer is dependent on the expression
levels of genes involved in mechanisms of chemoresistance and on the existence of genetic …

An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with …

SJ Wolf, M Bachtiar, J Wang, TS Sim… - The …, 2011 - nature.com
The human ABCB1 protein,(P-glycoprotein or MDR1) is a membrane-bound glycoprotein
that harnesses the energy of ATP hydrolysis to drive the unidirectional transport of …

Regional P‐glycoprotein activity and inhibition at the human blood–brain barrier as imaged by positron emission tomography

S Eyal, B Ke, M Muzi, JM Link… - Clinical …, 2010 - Wiley Online Library
We used positron emission tomography (PET) to evaluate the contribution of P‐glycoprotein
(P‐gp), present at the human blood–brain barrier (BBB), to regional drug distribution in the …

ABCB1 1199G>A Genetic Polymorphism (Rs2229109) Influences the Intracellular Accumulation of Tacrolimus in HEK293 and K562 Recombinant Cell Lines

G Dessilly, L Elens, N Panin, A Capron, A Decottignies… - Plos one, 2014 - journals.plos.org
Objective ATP-binding cassette, subfamily B, member 1 (ABCB1) transporter, or P-
glycoprotein, is an efflux protein implicated in the absorption and the distribution of various …